Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.
Novo Nordisk Foundation to launch $260M vaccine initiative in early 2024
The Novo Nordisk Foundation, which operates independently from the pharma company, is pumping DKK 1.8 billion ($260 million) to launch an initiative designed to develop